In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy. [electronic resource]
- Clinical endocrinology Apr 2001
- 469-77 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
0300-0664
10.1046/j.1365-2265.2001.01080.x doi
Acromegaly--drug therapy Adrenocorticotropic Hormone--analysis Adult Aminoquinolines--therapeutic use Analysis of Variance Antineoplastic Agents, Hormonal--therapeutic use Cabergoline Dopamine Agonists--therapeutic use Ergolines--therapeutic use Female Follicle Stimulating Hormone--analysis Growth Hormone--analysis Humans Immunohistochemistry Indium Radioisotopes--metabolism Insulin-Like Growth Factor I--analysis Iodine Radioisotopes--metabolism Luteinizing Hormone--analysis Male Octreotide--metabolism Pituitary Neoplasms--complications Prolactin--analysis Prolactinoma--complications Receptors, Dopamine--metabolism Receptors, Somatostatin--metabolism Thyrotropin--analysis Tumor Cells, Cultured--drug effects